Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer
about
Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cellsConditional Wwox deletion in mouse mammary gland by means of two Cre recombinase approaches.WWOX suppresses KLF5 expression and breast cancer cell growthWWOX expression in colorectal cancer--a real-time quantitative RT-PCR study.The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct bindingAndrogen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options.Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition.Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical featuresRegulation of cell signaling and apoptosis by tumor suppressor WWOX.Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.Adjuvant therapy of triple negative breast cancer.WWOX gene and gene product: tumor suppression through specific protein interactions.WWOX: a fragile tumor suppressor.Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis.Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.Wwox inactivation enhances mammary tumorigenesis.Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.Immunohistochemical expression of epidermal growth factor receptor in breast cancer.Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future DirectionsLoss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axisSomatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer
P2860
Q24626014-A5D15DE2-DC1D-4B92-95C6-88E406BCCC73Q34264825-15C2FEB4-BF22-4D7A-8EDC-C7312EC59A3FQ34452812-4AFB0E02-A5F0-4B82-BF88-CF5C11573A1EQ34978090-A567A38C-F148-4B28-A092-29DE59678EACQ35065263-6E463442-8522-4164-AEE8-8113FC4F0D24Q35088745-D2D31E76-B87E-4DA6-A6D8-AD5883DE1089Q35353424-827B7B41-EBA2-4D94-A6AA-B53D146820D2Q36914825-CDDEBE42-54BC-4516-A98D-4B25B00951F6Q37071049-3972473B-283B-4D7A-B032-06DEE44ECD73Q37071054-7D7DD2B9-B1E1-434A-8527-98A4DDDC5E39Q37571648-40AD9A6B-5B8B-4843-9C87-E1DB8A84B596Q37690302-5EBE2E5A-5080-43DB-BB16-F3ED869B562FQ38299692-FF5B7682-98EF-4C47-A6E6-7D32E41B237AQ38817885-D3BB8EAC-F4B9-4A90-B5CA-6CBC23D2C87DQ38962085-C58FC14C-D6FD-4FBE-B8C2-7BFB525F31B7Q39557407-614A7F18-7404-4336-A7F9-E4F55A464F2BQ50753687-9C00CAFC-86E8-4D5C-8DDE-E56B961D8A77Q54688681-66F27978-DCE5-4924-B19B-3B13782135A2Q57107482-FC8147C5-7798-4749-858B-AFF79F427DADQ58699452-17BF81F6-8152-422A-B080-8EF2AAF56F71Q58799648-266A53ED-7F34-4A26-8DC6-602D6B72914F
P2860
Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fragile histidine triad protei ...... sal phenotype in breast cancer
@ast
Fragile histidine triad protei ...... sal phenotype in breast cancer
@en
Fragile histidine triad protei ...... sal phenotype in breast cancer
@nl
type
label
Fragile histidine triad protei ...... sal phenotype in breast cancer
@ast
Fragile histidine triad protei ...... sal phenotype in breast cancer
@en
Fragile histidine triad protei ...... sal phenotype in breast cancer
@nl
prefLabel
Fragile histidine triad protei ...... sal phenotype in breast cancer
@ast
Fragile histidine triad protei ...... sal phenotype in breast cancer
@en
Fragile histidine triad protei ...... sal phenotype in breast cancer
@nl
P2093
P2860
P356
P1433
P1476
Fragile histidine triad protei ...... sal phenotype in breast cancer
@en
P2093
Charles L Shapiro
Cigdem Himmetoglu
Gulnur Guler
Kay Huebner
Mutlu Hayran
Rafael E Jimenez
Robert T Pilarski
Stefan Costinean
P2860
P304
P356
10.1002/CNCR.24103
P407
P577
2009-02-15T00:00:00Z